0001493152-24-032463.txt : 20240814 0001493152-24-032463.hdr.sgml : 20240814 20240814191902 ACCESSION NUMBER: 0001493152-24-032463 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20240812 FILED AS OF DATE: 20240814 DATE AS OF CHANGE: 20240814 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Morris Jeffrey Allen CENTRAL INDEX KEY: 0001959175 ORGANIZATION NAME: FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-36457 FILM NUMBER: 241210147 MAIL ADDRESS: STREET 1: 1729 TRIANGLE PARK DR. CITY: MARYVILLE STATE: TN ZIP: 37801 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: PROVECTUS BIOPHARMACEUTICALS, INC. CENTRAL INDEX KEY: 0000315545 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] ORGANIZATION NAME: 03 Life Sciences IRS NUMBER: 900031917 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 800 S. GAY STREET STREET 2: SUITE 1610 CITY: KNOXVILLE STATE: TN ZIP: 37929 BUSINESS PHONE: (866) 594-5999 MAIL ADDRESS: STREET 1: 800 S. GAY STREET STREET 2: SUITE 1610 CITY: KNOXVILLE STATE: TN ZIP: 37929 FORMER COMPANY: FORMER CONFORMED NAME: PROVECTUS PHARMACEUTICALS INC DATE OF NAME CHANGE: 20020417 FORMER COMPANY: FORMER CONFORMED NAME: ZAMAGE DIGITAL IMAGING INC DATE OF NAME CHANGE: 20011126 FORMER COMPANY: FORMER CONFORMED NAME: SPM GROUP INC DATE OF NAME CHANGE: 19920703 4 1 ownership.xml X0508 4 2024-08-12 0 0000315545 PROVECTUS BIOPHARMACEUTICALS, INC. PVCT 0001959175 Morris Jeffrey Allen 1729 TRIANGLE PARK DRIVE MARYVILLE TN 37801 0 0 1 0 0 Common Stock 12000000 D Common Stock 6500000 I By IRA Series D-1 Convertible Preferred Stock 2024-08-12 4 C 0 264314 2.862 A 4260061 D The reporting person has sole voting and dispositive power over 12,000,000 shares of Common Stock. The reporting person has sole voting and dispositive power over 6,500,000 shares of Common Stock owned through an IRA retirement plan. The reporting person has sole voting and dispositive power over 4,260,061 shares of Series D-1 Convertible Preferred Stock, convertible into 42,600,610 shares of Common Stock. /s/ Jeffrey Allen Morris 2024-08-14